Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06595355
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-10
Brief Title:
Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin in Diabetic Macular Edema
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effectiveness of adding curcumin oral treatment to bevacizumab intravitreal injection in patients with central macular edema
A blind study and a randomized and controlled clinical trial are conducted on diabetic patients with macular edema The patients are divided into two intervention groups bevacizumab curcumin and control bevacizumab placebo
The evaluation of the central thickness of the macula and the evaluation of the central volume of the macula are the primary goals and the evaluation of the best visual acuity of the patient is the secondary goal
A blind study and a randomized and controlled clinical trial are conducted on diabetic patients with macular edema The patients are divided into two intervention groups bevacizumab curcumin and control bevacizumab placebo
The evaluation of the central thickness of the macula and the evaluation of the central volume of the macula are the primary goals and the evaluation of the best visual acuity of the patient is the secondary goal
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None